Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sabbadini

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Cancer Cell|March 15, 2006
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineagesBarbara Visentin, John A Vekich, Bradley J Sibbald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal CancerLiang Zhang, Xiaoen Wang, Andrea J Bullock, et al.
Journal of Neuroinflammation|March 1, 2014
Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomesPeter J Crack, Moses Zhang, Maria Cristina Morganti-Kossmann, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Cancer Cell|March 15, 2006
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineagesBarbara Visentin, John A Vekich, Bradley J Sibbald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal CancerLiang Zhang, Xiaoen Wang, Andrea J Bullock, et al.
Journal of Neuroinflammation|March 1, 2014
Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomesPeter J Crack, Moses Zhang, Maria Cristina Morganti-Kossmann, et al.
Pageof 7